Request Deal Involvement
Mirum Pharmaceuticals to acquire Bile Acid Product Portfolio from Travere Therapeutics fot $445m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Evercore
legal advisors
Gibson Dunn & Crutcher
financial advisors
Morgan Stanley
legal advisors
Latham & Watkins
pr advisors
Argot Partners
financial advisors
Lazard
legal advisors
Cooley
or
Principals
bidder
MIRUM PHARMACEUTICALS
target
TRAVERE THERAPEUTICS (BILE ACID PRODUCT PORTFOLIO)
vendor
TRAVERE THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite